Mountain Pacific Investment Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,800
Closed -$177K 184
2018
Q3
$177K Buy
+1,800
New +$166K 0.02% 117
2016
Q4
Sell
-2,504
Closed -$216K 103
2016
Q3
$216K Hold
2,504
0.02% 101
2016
Q2
$217K Buy
+2,504
New +$202K 0.02% 99
2015
Q3
Sell
-2,919
Closed -$216K 107
2015
Q2
$216K Hold
2,919
0.03% 101
2015
Q1
$228K Buy
2,919
+119
+4% +$9.02K 0.03% 101
2014
Q4
$202K Buy
+2,800
New +$195K 0.02% 107
2014
Q3
Sell
-4,300
Closed -$274K 105
2014
Q2
$274K Buy
4,300
+700
+19% +$42.5K 0.03% 93
2014
Q1
$222K Hold
3,600
0.03% 99
2013
Q4
$207K Buy
+3,600
New +$204K 0.03% 102
2013
Q3
Sell
-4,250
Closed -$219K 97
2013
Q2
$219K Buy
+4,250
New +$210K 0.03% 92

Other funds holding MDT

Mountain Pacific Investment Advisers's MDT Position: Q4 2018 in Review

Mountain Pacific Investment Advisers sold out of Medtronic (MDT) in Q4 2018, closing a stake of 1,800 shares — an estimated $177K sold.

Mountain Pacific Investment Advisers first reported a position in MDT in Q2 2013 and held it in 10 quarters. The position peaked at $274K in Q2 2014. 1,563 funds tracked by Wall St. Rank hold MDT as of Q4 2018.

  • Mountain Pacific Investment Advisers reported no remaining Medtronic position as of Q4 2018 after selling out during the quarter.
  • Mountain Pacific Investment Advisers sold 1,800 Medtronic shares in Q4 2018, an estimated $177K.
  • Mountain Pacific Investment Advisers first reported a position in Medtronic in Q2 2013 and held it in 10 quarters.
  • Mountain Pacific Investment Advisers's Medtronic position peaked at $274K in Q2 2014.
  • 1,563 funds tracked by Wall St. Rank held Medtronic as of Q4 2018.

Based on Mountain Pacific Investment Advisers's 13F filing for Q4 2018, filed 25 Jan 2019.